PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.71%
Negative net income growth while MRVL stands at 4.77%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-6.51%
Negative yoy D&A while MRVL is 38.42%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-67.39%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
124.78%
Well above MRVL's 76.63% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
134.62%
Some inventory rise while MRVL is negative at -10.23%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
121.14%
Lower 'other working capital' growth vs. MRVL's 427.09%. David Dodd would see fewer unexpected short-term demands on cash.
-617.65%
Negative yoy while MRVL is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
101.67%
Operating cash flow growth above 1.5x MRVL's 66.88%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
22.46%
Some CapEx rise while MRVL is negative at -52.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
4.40%
Purchases well above MRVL's 6.60%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-41.55%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-97.00%
Both yoy lines negative, with MRVL at -387.62%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-42.70%
Negative yoy issuance while MRVL is 589.47%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
33.33%
Buyback growth of 33.33% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.